Here, we describe a new approach for mutational scanning of PCR products th
rough hybridization analysis between complementary oligonucleotides. Sets o
f overlapping probe oligonucleotides complementary to wild-type (WT) sequen
ce are hybridized to microbead-immobilized PCR products under solution-like
conditions. Mismatch-hybridization situations between a mutant sample and
probe oligonucleotides result in higher remaining concentrations in solutio
n of involved probe oligonucleotides. Post-hybridization supernatants are s
ubsequently analyzed for their probe oligonucleotide compositions using sur
face plasmon resonance-based biosensor technology Relative remaining probe
oligonucleotide concentrations are monitored in real-time through hybridiza
tion analysis between probe oligonucleotides and their corresponding sensor
-chip immobilized complementary counterparts. This allows for the construct
ion of composition diagrams revealing the existence and approximate locatio
n of a mutation within an investigated sample DNA sequence. Applied on PCR
products derived from clinical samples of microdissected tumor biopsies, si
ngle mutations in exons 6 and 7 of the human p53 tumor-suppressor gene were
successfully detected and approximately localized.